Thomas L Harrison - Net Worth and Insider Trading
Thomas L Harrison Net Worth
The estimated net worth of Thomas L Harrison is at least $193,881 dollars as of 2024-04-28. Thomas L Harrison is the Director of AFC Gamma Inc and owns about 15,028 shares of AFC Gamma Inc (AFCG) stock worth over $177,631. Thomas L Harrison is the Director of Zynerba Pharmaceuticals Inc and owns about 12,500 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $16,250. Thomas L Harrison is also the Director of Fifth Street Asset Management Inc and owns about 0 shares of Fifth Street Asset Management Inc (FSAM) stock worth over $0. Details can be seen in Thomas L Harrison's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas L Harrison has not made any transactions after 2021-03-23 and currently still holds the listed stock(s).
Transaction Summary of Thomas L Harrison
Thomas L Harrison Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas L Harrison owns 8 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , Fifth Street Asset Management Inc (FSAM) , and PLx Pharma Winddown Corp (PLXPQ) among others .
Click here to see the complete history of Thomas L Harrison’s form 4 insider trades.
Insider Ownership Summary of Thomas L Harrison
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals Inc | 2016-05-25 | director |
| FSAM | Fifth Street Asset Management Inc | 2017-12-08 | director |
| PLXPQ | PLx Pharma Winddown Corp | 2014-03-12 | director |
| RVUE | RVUE Holdings Inc | 2013-12-03 | director |
| MHGC | Morgans Hotel Group Co | 2012-05-17 | director |
| OMC | Omnicom Group Inc | 2004-06-29 | Chrmn/CEO Divers. Agency Serv. |
| ACXP | Acurx Pharmaceuticals Inc | 2021-06-24 | director |
| AFCG | AFC Gamma Inc | 2021-03-23 | director |
Thomas L Harrison Latest Holdings Summary
Thomas L Harrison currently owns a total of 3 stocks. Among these stocks, Thomas L Harrison owns 15,028 shares of AFC Gamma Inc (AFCG) as of March 23, 2021, with a value of $177,631 and a weighting of 91.62%. Thomas L Harrison owns 12,500 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of August 10, 2015, with a value of $16,250 and a weighting of 8.38%. Thomas L Harrison also owns 0 shares of Fifth Street Asset Management Inc (FSAM) as of December 8, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Thomas L Harrison
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AFCG | AFC Gamma Inc | 2021-03-23 | 15,028 | 11.82 | 177,631 |
| ZYNE | Zynerba Pharmaceuticals Inc | 2015-08-10 | 12,500 | 1.30 | 16,250 |
| FSAM | Fifth Street Asset Management Inc | 2017-12-08 | 0 | 0.01 | 0 |
Holding Weightings of Thomas L Harrison
Thomas L Harrison Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas L Harrison has made a total of 1 transactions in AFC Gamma Inc (AFCG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AFC Gamma Inc is the acquisition of 5,000 shares on March 23, 2021, which cost Thomas L Harrison around $95,000.
According to the SEC Form 4 filings, Thomas L Harrison has made a total of 0 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years. The most-recent trade in Zynerba Pharmaceuticals Inc is the acquisition of 12,500 shares on August 10, 2015, which cost Thomas L Harrison around $175,000.
According to the SEC Form 4 filings, Thomas L Harrison has made a total of 0 transactions in Fifth Street Asset Management Inc (FSAM) over the past 5 years. The most-recent trade in Fifth Street Asset Management Inc is the sale of 6,000 shares on December 8, 2017, which brought Thomas L Harrison around $24,300.
Insider Trading History of Thomas L Harrison
- 1
Thomas L Harrison Trading Performance
GuruFocus tracks the stock performance after each of Thomas L Harrison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas L Harrison is -32.24%. GuruFocus also compares Thomas L Harrison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas L Harrison within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas L Harrison's insider trading performs compared to the benchmark.
Performance of Thomas L Harrison
Average Return
-39.85%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.5 | -32.24 | -39.95 | -39.85 | -39.56 | -28.99 |
| Relative Return to S&P 500(%) | -11.34 | -35.94 | -40.84 | -48.52 | -43.62 | -39.3 |
Thomas L Harrison Ownership Network
Ownership Network List of Thomas L Harrison
Ownership Network Relation of Thomas L Harrison
Thomas L Harrison Owned Company Details
What does Zynerba Pharmaceuticals Inc do?
Who are the key executives at Zynerba Pharmaceuticals Inc?
Thomas L Harrison is the director of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .
Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary
Over the past 18 months, Thomas L Harrison made no insider transaction in Zynerba Pharmaceuticals Inc (ZYNE). Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 53,283 shares made by Armando Anido , a net sale of 37,062 shares made by Terri B Sebree , and a net sale of 26,767 shares made by James E Fickenscher .
In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,381 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,381 shares.
Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zynerba Pharmaceuticals Inc Insider Transactions
Thomas L Harrison Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas L Harrison. Currently GuruFocus does not have mailing address information for Thomas L Harrison.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
